Macrophage migration inhibitory factor plays an essential role in ischemic preconditioning-mediated cardioprotection

Clinical Science
Amanguli RuzeXiao-Ming Gao

Abstract

Ischemic preconditioning (IPC) is an endogenous protection strategy against myocardial ischemia-reperfusion (I/R) injury. Macrophage migration inhibitory factor (MIF) released from the myocardium subjected to brief periods of ischemia confers cardioprotection. We hypothesized that MIF plays an essential role in IPC-induced cardioprotection. I/R was induced either ex vivo or in vivo in male wild-type (WT) and MIF knockout (MIFKO) mice with or without proceeding IPC (three cycles of 5-min ischemia and 5-min reperfusion). Indices of myocardial injury, regional inflammation and cardiac function were determined to evaluate the extent of I/R injury. Activations of the reperfusion injury salvage kinase (RISK) pathway, AMP-activated protein kinase (AMPK) and their downstream components were investigated to explore the underlying mechanisms. IPC conferred prominent protection in WT hearts evidenced by reduced infarct size (by 33-35%), myocyte apoptosis and enzymatic markers of tissue injury, ROS production, inflammatory cell infiltration and MCP1/CCR2 expression (all P<0.05). IPC also ameliorated cardiac dysfunction both ex vivo and in vivo These protective effects were abolished in MIFKO hearts. Notably, IPC mediated further activation...Continue Reading

References

Apr 1, 1990·Circulation Research·R J SchottW Schaper
Jul 31, 1993·Lancet·D M YellonW B Pugsley
Feb 14, 2004·Cardiovascular Research·Stephen C Armstrong
Sep 11, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Derek J HausenloyDerek M Yellon
Sep 25, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Monte S WillisBrett P Giroir
Jan 12, 2005·Circulation·Laurent ArgaudMichel Ovize
May 12, 2005·Trends in Cardiovascular Medicine·Derek J HausenloyDerek M Yellon
Mar 7, 2006·Cardiovascular Research·Robert A Kloner, Shereif H Rezkalla
Jul 7, 2007·Journal of Applied Physiology·Jakob Vinten-JohansenGeoffrey P Dobson
Aug 4, 2007·Pflügers Archiv : European journal of physiology·Yeshi HuJin-Song Bian
Aug 19, 2007·Inflammation & Allergy Drug Targets·Ying Xia, Nikolaos G Frangogiannis
Sep 15, 2007·The New England Journal of Medicine·Derek M Yellon, Derek J Hausenloy
Apr 29, 2009·Cardiovascular Research·Asger GranfeldtJakob Vinten-Johansen
May 28, 2010·Cardiovascular Drugs and Therapy·Xiulan YangJames M Downey
Jun 10, 2010·Cardiovascular Drugs and Therapy·Zhi-Qing Zhao
Aug 23, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Shoji SanadaMasafumi Kitakaze
Jan 21, 2012·Pharmacology & Therapeutics·Xiao-Ming GaoXiao-Jun Du
Apr 17, 2012·Circulation Journal : Official Journal of the Japanese Circulation Society·Tetsuo Minamino
Nov 9, 2012·Journal of Cardiovascular Electrophysiology·Joan DowRobert A Kloner
Sep 3, 2013·Journal of Molecular and Cellular Cardiology·Tanner M FullmerSihem Boudina

❮ Previous
Next ❯

Citations

Apr 20, 2019·Clinical Science·Jürgen Bernhagen
Jan 7, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Rosario CaltabianoPaolo Fagone

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis